Home / Tools / Cell lines / Cyclin A2-Venus Reporter Cell Line [RPE1 cycA2-venus/+ KI clone D6]
Cyclin A2-Venus Reporter Cell Line [RPE1 cycA2-venus/+ KI clone D6]
Exclusive Tool
Contributors
Inventor
Institute
Jonathon Pines
University of Cambridge
SKU:
153463
Product description:
Somatic knock-in reporter cell line with endogenous expression of Cyclin A2 fused to the yellow fluorescent protein Venus (Cyclin A2-Venus fusion protein). Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. Cyclin A binds and activates CDC2 or CDK2 kinases, and thus this cell line functions as a reporter for both cell cycle G1/S and G2/M transitions. See also the Mad2 and Cyclin B1 versions of these cell lines for a broader analysis of the different phases of the cell cycle. This cell line is an endogenous reporter for Cyclin A2 levels and activity.
Alternate name:
CCNA2
Conditional:
No
Production details:
To generate the cell line recombinant adenovirus-associated virus (rAAV)-mediated gene targeting was used to introduce the open reading frame (ORF) of yellow fluorescent protein (Venus) into the last exon of one allele of the CCNA2 (Cyclin A2) gene in hTert-RPE1 cells (RPE1; retinal pigment epithelial). RPE1 cells were chosen because they have a normal diploid karyotype, are not transformed and exhibit little cell death when arrested in mitosis; tagging the endogenous Cyclin A2 protein in RP…
Parental cell line:
RPE1
Cat. #:
153463
Provenance and Ownership:
The Cyclin A2-Venus Reporter Cell Line [RPE1 cycA2-venus/+ KI clone D6] is owned by Cancer Research UK. CancerTools supplies the Cyclin A2-Venus Reporter Cell Line [RPE1 cycA2-venus/+ KI clone D6] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Cyclin A2-Venus Reporter Cell Line [RPE1 cycA2-venus/+ KI clone D6] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements.
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.